Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer
Clinical trial NCT02017015 · COMPLETED
Trial details
- NCT number
- NCT02017015
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-24
- Primary completion
- 2015-06-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.